S
CLBT icon

SignatureFD’s Cellebrite CLBT Stock Holding History

SignatureFD’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.5K Hold
1,200
– – ﹤0.01% 2406
2026
Q1 		$16.5K Sell
1,200
-819
-41% -$12.3K ﹤0.01% 2288
2025
Q4 		$36.4K Hold
2,019
– – ﹤0.01% 1831
2025
Q3 		$37.4K Hold
2,019
– – ﹤0.01% 1797
2025
Q2 		$32.3K Buy
2,019
+819
+68% +$14.6K ﹤0.01% 1827
2025
Q1 		$23.3K Hold
1,200
– – ﹤0.01% 1989
2024
Q4 		$26.4K Hold
1,200
– – ﹤0.01% 1917
2024
Q3 		$20.2K Hold
1,200
– – ﹤0.01% 2035
2024
Q2 		$14.3K Sell
1,200
-300
-20% -$3.35K ﹤0.01% 2118
2024
Q1 		$16.6K Sell
1,500
-283
-16% -$2.89K ﹤0.01% 2089
2023
Q4 		$15.4K Buy
1,783
+300
+20% +$2.33K ﹤0.01% 2053
2023
Q3 		$11.3K Hold
1,483
– – ﹤0.01% 2141
2023
Q2 		$10.7K Hold
1,483
– – ﹤0.01% 2208
2023
Q1 		$9.03K Hold
1,483
– – ﹤0.01% 2261
2022
Q4 		$6.47K Hold
1,483
– – ﹤0.01% 2333
2022
Q3 		$6K Hold
1,483
– – ﹤0.01% 2327
2022
Q2 		$8K Hold
1,483
– – ﹤0.01% 2215
2022
Q1 		$9K Buy
+1,483
New +$9.83K ﹤0.01% 2192

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

SignatureFD's CLBT Position: Q2 2026 in Review

SignatureFD held its Cellebrite (CLBT) position steady in Q2 2026 at 1,200 shares worth $17.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2406.

SignatureFD first reported a position in CLBT in Q1 2022 and has held it in 18 quarters since. The position peaked at $37.4K in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • SignatureFD held 1,200 shares of Cellebrite worth $17.5K as of Q2 2026.
  • SignatureFD left its Cellebrite share count unchanged in Q2 2026.
  • Cellebrite made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2406 holding.
  • SignatureFD first reported a position in Cellebrite in Q1 2022 and has held it in 18 quarters since.
  • SignatureFD's Cellebrite position peaked at $37.4K in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.